Clinical Trial Update: Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating immunotherapy to avoid surgery in patients with mismatch repair-deficient endometrial cancer. The study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Endometrial Cancer, Immunotherapy | Phase 2 | Status: NOT_YET_RECRUITING